Breast Cancer after Hodgkin's Lymphoma: An Observational Study
Francesco Milardi(University of Padua), Laura Evangelista(Istituto Oncologico Veneto), Matteo Cagol(Istituto Oncologico Veneto), Tajna Kraljic(Istituto Oncologico Veneto), Silvia Michieletto(Istituto Oncologico Veneto), Massimo Ferrucci(Istituto Oncologico Veneto), Mariacristina Toffanin(Istituto Oncologico Veneto), Fernando A. Bozza(D’Or Institute for Research and Education), Tania Saibene(Istituti di Ricovero e Cura a Carattere Scientifico), L. Rigato, Daniele Passeri(University of Padua), Alberto Marchet(Istituto Oncologico Veneto)
Cited by 0
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
|Science Translational Medicine|2010|492